A US hospital did not want to treat an intensive care patient seriously ill with Covid with the agent ivermectin – until a judge ordered its use. The patient’s condition quickly improved. The clinic is still sticking to the rejection of ivermectin.
A Hong Kong-born Covid-19 patient recovered at a hospital in Naperville, Greater Chicago, Illinois after being given the drug ivermectin. The 71-year-old came to the United States in October to celebrate his granddaughter’s first birthday and contracted the virus there. After his condition worsened, his daughter desperately asked the hospital to treat him with ivermectin. This was dismissed with reference to the applicable medical guidelines, in which the drug is classified as ineffective.
The decision finally had to be made in early November be hit by a judge, who rejected the hospital’s objections: he could not imagine “a more extraordinary situation” than when someone’s life was at stake. Therefore, he asked the hospital to refer to the internist Dr. Allow Alan Bain to give ivermectin to the patient. After five days, the 71-year-old was able to breathe on his own again and was able to go to the hospital left on November 16th. But even after that, the hospital appealed the judge’s decision, and continues to reject ivermectin.
The use of ivermectin has already been established in India, especially in the state Uttar Pradesh, proven to be extremely successful, especially in relation to regions that rely entirely on Covid vaccines. The funds, which cost only about $ 3, contributed significantly to containing the first wave of Covid in the summer of last year. Despite the high population density and the highest number of inhabitants of all Indian states, the number of infections in Uttar Pradesh has been stabilized at a relatively low level.